Serialization has been widely discussed by the pharmaceutical industry over the last five years and as the regulatory deadlines in Europe and the US get closer, the challenges associated with developing and implementing a robust solution are growing.

In this two-part roundtable with Manufacturing Chemist, our director of corporate strategy, Dexter Tjoa, discusses the biggest hurdles companies are facing because of serialization legislation and what they should be looking for in contract partners should they decide to outsource their requirements.

He also explores the benefits of implementing serialization solutions beyond simply achieving compliance and what full track & trace systems could mean for the future of the industry.

Read part one of the roundtable here: The Manufacturing Chemist anticounterfeiting roundtable: part I

Read part two of the roundtable here: The Manufacturing Chemist anticounterfeiting roundtable: part II